[Multiple manifestations of intolerance in association with anti-inflammatory agents. Role of phenylbutazone].
D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury; D004342:Drug Hypersensitivity; D004361:Drug Tolerance; D004890:Erythema / Q000139:chemically induced; D005260:Female; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects; D007674:Kidney Diseases / Q000139:chemically induced; D008875:Middle Aged; D010653:Phenylbutazone / Q000009:adverse effects; D011696:Purpura, Thrombocytopenic / Q000139:chemically induced; D013921:Thrombocytopenia / Q000139:chemically induced
D000893:Anti-Inflammatory Agents; D010653:Phenylbutazone; D007213:Indomethacin
Manifestations multiples d'intolérance a une association d'anti-inflammatoires. Rôle de la phénylbutazone